 |
 |

Continuous Absorbable vs Interrupted Nonabsorbable Fascial ClosureA Prospective, Randomized Comparison
Paul M. McNeill, MD;
Harvey J. Sugerman, MD
Arch Surg. 1986;121(7):821-823.
Abstract
 |  |
A prospective, randomized comparison of continuous, absorbable, No. 2, coated, polyglycolic acid suture (DexonPlus) vs interrupted, nonabsorbable, No. 28 monofilament stainless steel wire suture was performed in 105 patients for midline fascial closure following gastric surgery for morbid obesity. The preoperative weight, sex distribution, and type of operation were not significantly different between the two groups. No significant difference was found in the wound complication rate between the two closure methods (7/54 for wire and 8/51 for polyglycolic acid). There were one dehiscence and five incisional hernias in the wire group and five hernias in the polyglycolic acid group. Continuous closure was accomplished in significantly less time (21±8 minutes) than interrupted closure (43±19 minutes). An additional 121 patients underwent continuous No. 2 polyglycolic acid fascial closure after the end of the randomized trial, with 13 wound complications, including ten incisional hernias. In conclusion, continuous, absorbable suture closure for laparotomy wounds is recommended for its economy of time and the lack of significant difference from an interrupted, nonabsorbable wound closure.
(Arch Surg 1986;121:821-823)
Author Affiliations
From the Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond.
Footnotes
Accepted for publication Dec 2, 1985.
Presented at the First Annual Meeting of the American Society for Bariatric Surgery, Iowa City, June 12, 1985.
Reprint requests to Medical College of Virginia, PO Box 519, MCV Station, Richmond, VA 23298-0001 (Dr Sugerman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Objective Analysis of the Accuracy and Efficacy of a Novel Fascial Closure Device
Williams et al.
SURG INNOV 2008;15:307-311.
ABSTRACT
Transforming Growth Factor {beta}3 Promotes Fascial Wound Healing in a New Animal Model
Tyrone et al.
Arch Surg 2000;135:1154-1159.
ABSTRACT
| FULL TEXT
|